BÂRRX Medical, Inc.

Bookmark and Share

HALO Products

References

  1. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99:918-22.
  2. "Study provides first estimate of U.S. population affected by Barrett's esophagus." Gastro.org. 2006. American Gastroenterological Association.
    www.gastro.org/wmspage.cfm?parm1=1834
    Accessed August 2007.
  3. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129:1825-1831.
  4. Heiko Pohl and H.G. Welch. The role of over diagnosis and reclassification in the Marked Increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005: 97: 142-146.
  5. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's esophagus in high-risk patients with chronic gerd. Gastrointestinal Endosc. 2005; 61:226-231.
  6. Reid B.J and Weinstein W. M. Barrett's esophagus and adenocarcinoma. Gastroenterology Clinics of North America 1987; 38: 477-492.
  7. G.M. Eisen. Ablation therapy for Barrett's esophagus. Gastrointestinal Endosc. 2003; 58: 760-769. 5
  8. "What Are the Key Statistics about Cancer of the Esophagus?" Cancer.org. 2006. American Cancer Society.
    www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_
    statistics_for_esophagus_cancer_12.asp?sitearea=
    Accessed October 2007.
  9. Ganz RA, Utley DS, Stern RA, et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004; 60:1002-10.
  10. Dunkin BJ, Martinez J, Bejarano PA, et al; Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surgical Endoscopy 2006; 20: 125-130.
  11. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65:185-194.
  12. Fleischer DE, Overholt BF, Sharma VK, et al. Long-term (2.5 year) follow-up of the AIM-II trial for ablation of Barrett's esophagus: results after primary circumferential ablation followed by secondary focal ablation. Gastrointest Endosc 2007; 65: AB 135.
  13. Smith CD, Bejarano PA, Melvin WS, et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007; 21:560-569.
  14. Gerson LB, Shetler K, and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;123:461-467
  15. "Fastest Rising Form of Cancer in the U.S." Webmd.com. 2005. WebMD.
    www.webmd.com/cancer/news/20050118/esophageal-cancer-on-rise
    Accessed October 2007.
  16. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett's esophagus and esophageal cancer. Journal of the American Medical Association. 2002; 287: 1972-1981.
  17. Sampliner RE. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97:1888–1895.
  18. Possible complications may include: mucosal laceration, perforation of the esophagus requiring surgery, infection, bleeding, and stricture formation requiring dilation. The overall complication rate reported for this procedure is approximately < .19%.
  19. Spechler SJ. Barrett's esophagus. N Engl J Med 2002; 346: 836-842.
  20. Gondrie JJ, Rygie AM, Sondermeijer C, et al. Balloon-based circumferential ablation followed by focal ablation of Barrett's esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology. 2007; Supplement S1: 132: A-64.
  21. Inadomi JM, Madanick RD, Somsouk M, Shaheen NJ. Radiofrequency ablation is more cost-effective than endoscopic surveillance or esophagectomy among patients with Barrett's esophagus and low-grade dysplasia. Gastroenterology. 2007; Supplement S1: 132: A-53.
  22. Ganz RA, Overholt BJ, Sharma VK, et al. HALO360+ circumferential ablation is safe and effective for the treatment of Barrett's esophagus and high-grade dysplasia: A U.S. multi-center registry. Gastrointest Endosc 2007; 65: AB 147.
  23. Sharma VK, Kim HJ, Musil D, Crowell MD, et al. Circumferential ablation of Barrett's esophagus with low-grade dysplasia: One and two year follow-up of the AIM-LGD Trial. Gastrointest Endosc. 2007; 65: AB155.
  24. Pouw RE, Gondrie JJ, Sondermeijer C, et al. Novel combined modality therapy for Barrett's esophagus containing high-grade dysplasia: Endoscopic mucosal resection followed by circumferential and focal ablation using the HALO system. Gastrointest Endosc 2007;65: AB111.
  25. Gondrie JJ, Pouw RE, Sondermeijer C, et al. Optimizing the technique for circumferential ablation of Barrett's esophagus containing high-grade dysplasia using the HALO360 system. Gastrointest Endosc 2007;65:AB 151.
  26. Rothstein RI, Chang K, Overholt BJ, et al. Focal ablation for treatment of dysplastic and non-dysplastic Barrett's esophagus: safety profile and initial experience with the HALO90 device in 508 cases. Gastrointest Endosc 2007;65: AB 147.
  27. Gondrie JJ, Peters F, Curvers WL, et al. Radiofrequency ablation of Barrett's esophagus containing high-grade dysplasia. Gastrointest Endosc 2007;65: AB 135.
  28. Beaumont H, Bergman JJ, Pouw RE, et al. Preservation of the functional integrity of the distal esophagus after circumferential ablation of Barrett's esophagus. Gastroenterology. 2007; Supplement S1: 132: A-255.
  29. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4:566-572
  30. BÂRRX Medical and the FDA MAUDE database (http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm)
  31. Curvers W, ten Kate F, Krishnadath K, et al. Low grade dysplasia in Barrrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol, 11 May 2010;doi:10.1038/ajg.2010.171.
  32. Fleischer D, Overholt B, Sharma V, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5 year follow-up. Gastrointest Endosc 2008;68:867-76.
  33. BARRX Medical, Inc. HALO Patient Registry data on file. 
  34. van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011;60:765-73.
  35. Friedman L. The Sensitive Gut. A Harvard Medical School Special Health Report. 2010.
  36. “Study provides first estimate of U.S. population affected by Barrett’s esophagus.” Gastro.org. 2006. American Gastroenterological Association. www.gastro.org/wmspage.cfm?parm1=1834; Accessed August 2007.